Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Overweight Rating on Zscaler with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Technology Robotics Stock Market Today
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Barclays analyst Saket Kalia has reiterated an Overweight rating on Zscaler, but has revised the price target to $240 from $259 as of March 1, 2024. This change is part of a series of adjustments in price targets for Zscaler, with previous targets ranging from $183 to $311. The recent upgrade by Barclays to an Overweight rating reflects their positive outlook on Zscaler’s performance and growth potential in the cloud security sector.

Other research firms have also expressed confidence in Zscaler, with a consensus recommendation of “Moderate Buy” and an average twelve-month target price of $218.74. Despite the price target adjustment, analysts remain optimistic about Zscaler’s market position and growth prospects.

ZS Stock Price Plummets on March 1, 2024: What Investors Need to Know

On March 1, 2024, ZS stock experienced a significant drop in price, opening at $226.95, which was $15.02 lower than its previous close. Throughout the day, the price of ZS shares continued to decrease, ending the day at $203.30, a decrease of $23.65 or 9.77% from the previous day’s closing price.

Despite this drop in price, ZS is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the long term, even though it experienced a significant drop in price on March 1.

Investors may be wondering what caused this sudden drop in price for ZS stock. It is important to note that stock prices can be influenced by a variety of factors, including market conditions, company performance, and investor sentiment. Without more information, it is difficult to pinpoint the exact reason for the drop in ZS stock price on March 1.

For investors considering buying or selling ZS stock, it is important to conduct thorough research and analysis to make informed decisions. While the drop in price on March 1 may be concerning, it is important to consider the stock’s overall performance and potential for future growth.

As always, it is recommended to consult with a financial advisor or investment professional before making any investment decisions. Stock prices can be volatile and unpredictable, so it is important to approach investing with caution and diligence.

ZS Stock Shows Positive Growth in Total Revenue and Net Income on March 1, 2024

On March 1, 2024, ZS stock showed positive growth in its total revenue and net income compared to the previous year and quarter. According to data from CNN Money, ZS reported a total revenue of $1.62 billion for the past year, which is a 48.22% increase from the previous year. In the first quarter of 2024, the total revenue was $496.70 million, showing a 9.16% increase from the previous quarter.

Similarly, the net income of ZS also saw growth, with a reported net loss of $202.34 million for the past year, which is a 48.16% improvement from the previous year. However, in the first quarter of 2024, the net loss was $33.48 million, showing a 9.16% decrease from the previous quarter.

Earnings per share (EPS) for ZS also showed positive growth, with an EPS of -$1.40 for the past year, representing a 49.6% increase from the previous year. In the first quarter of 2024, the EPS was -$0.23, showing an 8.26% decrease from the previous quarter.

Overall, the performance of ZS stock on March 1, 2024, reflects positive growth in total revenue, net income, and EPS compared to the previous year. Investors may view this as a promising sign of the company’s financial health and potential for future growth. However, the slight decrease in net income and EPS from the previous quarter may warrant further analysis.

Tags: ZS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Wind Farms: How Strategic Acquisitions Amplify the Impact of Green Energy Players

Equinor Expands Helicopter Fleet for Safety and Efficiency on NCS

Analysts Upgrade Vertex Pharmaceuticals with Bullish Price Targets

Software-solutions-technology

Analyst Remains Bullish on Xometry Despite Price Target Adjustment

Recommended

Oracle Stock

Oracle Shares Plunge as Investor Confidence Evaporates

3 months ago
Home Construction Trading online

Analyst Initiates Coverage on Installed Building Products with Buy Rating and 275 Price Target

2 years ago
Applied Materials Stock

Applied Materials: Navigating Market Volatility Amid AI-Driven Semiconductor Demand

5 months ago
Amazon Stock

Amazon’s Aggressive AI Expansion: Balancing Massive Investment with Market Expectations

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

National Healthcare’s Financial Report: A Crucial Test Approaches

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

Trending

CureVac Stock
Mergers & Acquisitions

CureVac Delisted Following BioNTech Acquisition Completion

by Andreas Sommer
February 5, 2026
0

The chapter for CureVac as an independent publicly traded company has officially closed. The biotech firm's shares...

EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026
NexPoint Residential Stock

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

February 4, 2026
PC Connection Stock

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

February 4, 2026
Fossil Stock

Fossil Group Stock Surges Past Key Technical Threshold

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CureVac Delisted Following BioNTech Acquisition Completion
  • Strategic Robotics Partnership Signals New Growth Phase for EOS Defence
  • NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com